3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
NIH
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
58
Dermatologic
4
Other
3
Lymphoid
3
Gynecologic
3
Classical hematology
3
Other hematologic neoplasm
2
Genitourinary
2
Endocrine
2
CNS
2
Thoracic
1
Sarcoma
1
Plasma cell
1
NET
1
Myeloid
1
Head & Neck
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
2265
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1734
Leukemia
1500
Leukemia, Lymphocytic, Chronic, B-Cell
1120
Myelodysplastic Syndromes
963
Hematologic Neoplasms
935
Lymphoma
739
Lymphoma, Non-Hodgkin
654
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
532
Multiple Myeloma
501
Lymphoma, Follicular
467
Hodgkin Disease
460
Lymphoma, Mantle-Cell
459
Burkitt Lymphoma
440
Lymphoma, Large B-Cell, Diffuse
433
Lymphoma, B-Cell, Marginal Zone
402
Recurrence
356
Leukemia, Myelomonocytic, Chronic
351
Myeloproliferative Disorders
330
Leukemia, Myeloid, Chronic-Phase
311
Lymphoma, Large-Cell, Immunoblastic
303
Congenital Abnormalities
273
Neoplasms
271
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
249
Blast Crisis
246
Leukemia, Myeloid, Accelerated Phase
244
Primary Myelofibrosis
221
Neoplasms, Plasma Cell
220
Waldenstrom Macroglobulinemia
216
Lymphoma, T-Cell, Cutaneous
197
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Inflammatory Bowel Diseases
×
Other hematologic neoplasm
×
Clear all
NCT07086989
2025-08-08
CR3C
Semmelweis University
Recruiting
300 enrolled
NCT00964210
2011-04-15
HPV
Murdoch Childrens Research Institute
Phase 3
Completed
240 enrolled